AstraZeneca to deliver vaccine trial data by year’s end
AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses in January, CEO Pascal Soriot said Thursday.